Responsible drug manufacturers and contract organizations share the common goal of producing the best possible product in the most efficient way. The two have shared mutually beneficial relationships for decades in the pharmaceutical industry and will no doubt continue to do so for years to come. The numbers support that continued success as well: according to an IntelliROI 2016 report, the global contract pharmaceutical manufacturing market is expected to reach $84 billion by 2020, up from $58 billion in 2014. What follows is an in-depth look at pharma’s outsourcing relationships from the contract manufacturing perspective — what works, what doesn’t, and how to…Full Story
As pharma looks more to biologics, they must face the challenges surrounding scientific complexity and sophisticated development.